AI assistant
Sending…
IN8BIO, INC. — Director's Dealing 2022
Aug 18, 2022
35200_dirs_2022-08-18_0b54cf82-22e8-4849-80a2-c47ea046d892.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IN8BIO, INC. (INAB)
CIK: 0001740279
Period of Report: 2022-08-16
Reporting Person: Rochlin Kate (Chief Operating Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-08-16 | Common Stock | P | 5263 | $1.90 | Acquired | 5263 | Direct |